Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical Rheumatology
Published in: Clinical Rheumatology 11/2020

01-11-2020 | Dermatomyositis | Clinical Image

Tumoral calcinosis in dermatomyositis

Authors: Mohammad Khudadah, Ali S. M. Jawad

Published in: Clinical Rheumatology | Issue 11/2020

Login to get access

Excerpt

A 31-year-old Bengali woman complained of discomfort on sitting on hard surfaces over the preceding few weeks. She also felt hard lumps on the junction of the buttocks and legs. Nine years earlier, she was diagnosed with dermatomyositis (DM) (proximal muscle weakness, very high creatine kinase, positive muscle biopsy, heliotrope rash, and interstitial lung disease with positive Jo-1 antibodies). Her DM was very severe especially the lungs requiring prednisolone and intravenous cyclophosphamide for 2 years. Currently, her condition was stable on weekly 12.5 mg methotrexate and 5 mg prednisolone. She walks slowly using a stick. …
Literature
1.
Boulman N, Slobodin G, Rozenbaum M, Rosner I (2005) Calcinosis in rheumatic diseases. Semin Arthritis Rheum 34:805–812CrossRef
Metadata
Title
Tumoral calcinosis in dermatomyositis
Authors
Mohammad Khudadah
Ali S. M. Jawad
Publication date
01-11-2020
Publisher
Springer International Publishing
Published in
Clinical Rheumatology / Issue 11/2020
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI
https://doi.org/10.1007/s10067-020-05268-0

Other articles of this Issue 11/2020

Clinical Rheumatology 11/2020 Go to the issue

Original Article

Efficacy and safety results from a randomized double-blind study comparing proposed biosimilar ABP 798 with rituximab reference product in subjects with moderate-to-severe rheumatoid arthritis

Original Article

The impact of COVID-19 pandemic on rheumatology practice: a cross-sectional multinational study

Perspectives in Rheumatology

Moving towards online rheumatology education in the era of COVID-19

Original Article

Clinical characteristics of systemic lupus erythematosus patients in long-term remission without treatment

Review Article

Managing rheumatic diseases during COVID-19

Review Article

Efficacy and safety of Romosozumab in treatment for low bone mineral density: a systematic review and meta-analysis

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits